Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Change in Cash (2016 - 2025)

Historic Change in Cash for Fresenius Medical Care AG (FMS) over the last 17 years, with Q3 2025 value amounting to -$542.3 million.

  • Fresenius Medical Care AG's Change in Cash fell 27936.01% to -$542.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$144.2 million, marking a year-over-year increase of 2710.41%. This contributed to the annual value of -$258.5 million for FY2024, which is 25657.51% down from last year.
  • As of Q3 2025, Fresenius Medical Care AG's Change in Cash stood at -$542.3 million, which was down 27936.01% from $726.1 million recorded in Q2 2025.
  • In the past 5 years, Fresenius Medical Care AG's Change in Cash registered a high of $726.1 million during Q2 2025, and its lowest value of -$542.3 million during Q3 2025.
  • In the last 5 years, Fresenius Medical Care AG's Change in Cash had a median value of -$53.6 million in 2023 and averaged $11.4 million.
  • Its Change in Cash has fluctuated over the past 5 years, first tumbled by 345872.27% in 2022, then soared by 94159.42% in 2025.
  • Over the past 5 years, Fresenius Medical Care AG's Change in Cash (Quarter) stood at -$91.7 million in 2021, then soared by 278.23% to $163.5 million in 2022, then plummeted by 196.84% to -$158.3 million in 2023, then plummeted by 36.27% to -$215.7 million in 2024, then tumbled by 151.4% to -$542.3 million in 2025.
  • Its last three reported values are -$542.3 million in Q3 2025, $726.1 million for Q2 2025, and -$112.2 million during Q1 2025.